Abstract:Hereditary spastic paraplegia (HSP) associated with thin corpus callosum (TCC) is an autosomal recessive complicated HSP characterized by normal motor development, followed by slowly progressive spastic paraparesis and mental deterioration. Recently, mutations of the SPG11 gene encoding the spatacsin protein have been identified as a major cause of HSP-TCC. SPG11 is located on chromosome 15q21.1, contains 40 exons and encodes a protein of 2,443 amino acids. Spatacsin function is not yet known, however, its widespread expression in the central nervous system and its highly conserved sequence among species indicate an important and essential role. Up to date, 10 mutations including four nonsense mutations, four small deletions and two small insertions of the SPG11 gene were found in 12 families of ARHSP-TCC. Here, we described two novel mutations of the SPG11 gene in two unrelated Chinese patients with HSP-TCC. Patient 1, a 24-year-old man, presented with a progressive speech disorder with mental deterioration impairing school performance(s) from the age of 7 years on. From the age of 14 onwards, he also developed leg stiffness and gait disturbance. There was no consanguinity, family history was unremarkable, and his birth and motor development had been normal. Neurologic examination at age 24 showed dysarthria, left foot muscle atrophy, lower limb symmetric spasticity, upper limb ataxia, and unsteady tandem walking. His Mini Mental State Examination (MMSE) score was 14/30. Ceruloplasmin was normal. Motor nerve conduction of the left peroneal nerve showed lowered amplitude. EMG examination showed denervation potentials in the anterior tibial muscles and the left gastrocnemius muscle. Brain MR Images (Fig 1a–c) disclosed thinning of the corpus callosum, especially in its anterior parts, slight hyperintense signal alterations in the periventricular white matter, as well as mild thalamic and cerebellar atrophy. Spinal cord MRI was normal. Patient 2, a 26-year-old man, born from consanguineous parents, suffered from slowly progessive dysarthria, accompanied by a gait disorder from the age of 18 onwards. He had difficulty in walking without assistance by the age of 23. His MMSE score was 6/30. Besides the dysarthria, and paraspasticity, there was additional hand muscle atrophy, and mild weakness of the lower limbs. Nerve conduction was normal. In the brain MRI (Fig 1d–f) there was slight enlargement of the lateral ventricles and a thin corpus callosum. Spine MRI revealed atrophy of the thoracic cord. Some of the dysarthria and spasticity symptoms of the patients improved under treatment with baclofen (45 mg/day) and D2 receptor agonist (Piribedil, 50 mg bid). Sequencing of the SPG11 gene revealed a novel homozygous small deletion (c.4307_4308del, Fig. 2A) in exon 25 in the first patient leading to a frameshift and early termination at amino acid residue 1,442. This was not found in 100 control chromosomes studied by direct sequencing (Fig. 2B). A homozygous c.5977C>T substitution was found in exon 31 in the second patient (Fig. 2C), leading to a termination at amino acid residue 1,993. All PCR products of exon 31 of 50 healthy controls were cut into 210 bp and 320 bp with Sall (Fig. 2E). This restriction site which is found in normal chromosomes was lost in patient 2. A homozygous c.833A>G substitution was also detected in exon 5 of the same patient (Fig. 2F), leading to an amino acid change (p.278N>S). This is likely a polymorphism since 4 out of 50 healthy controls were heterozygote for the same change (Fig. 2G). The two novel mutations found in the present report lead to a stop codon, providing further evidence for a loss of function mechanism. The difference of the severity and onset age of these two patients may be due to differences in spatacsin dysfunction resulting from the two mutations. However, a precise genotype-phenotype correlation is not yet possible, due to the small overall number of patients with SPG11 mutations described so far. This report points to the importance of screening the SPG11 gene for additional mutations in more families with HSP-TCC.

A Novel MAG Variant Causes Hereditary Spastic Paraplegia in a Consanguineous Pakistani Family

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

Identification and analyses of exonic and copy number variants in spastic paraplegia

A novel variant (p.A524P) in Spastin is responsible for a Chinese family with hereditary spastic paraplegia

Investigating the genetic basis of hereditary spastic paraplegia and cerebellar Ataxia in Pakistani families

A Novel SPAST Gene Mutation Identified in a Chinese Family with Hereditary Spastic Paraplegia

A novel variant causes pure hereditary spastic paraplegia with benign clinical course.

Two Novel Mutations in the SPG11 Gene Causing Hereditary Spastic Paraplegia Associated with Thin Corpus Callosum

Three Iranian patients with rare subtypes of hereditary spastic paraplegia (HSP): SPG76, SPG56, and SPG69

A novel missense mutation in SPAST causes hereditary spastic paraplegia in male members of a family: A case report

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST

Novel mutation of SPG4 gene in a Chinese family with hereditary spastic paraplegia: A case report

A Novel Nonsense Variant in GRM1 Causes Autosomal Recessive Spinocerebellar Ataxia 13 in a Consanguineous Pakistani Family

Microdeletion in Distal PLP1 Enhancers Causes Hereditary Spastic Paraplegia 2.

Expanding the genetic spectrum of hereditary motor sensory neuropathies in Pakistan

A retrospective review of 18 patients with childhood-onset hereditary spastic paraplegia, nine with novel variants

Novel Deletion of SPAST in a Chinese Family with Hereditary Spastic Paraplegia

Genetic and structural analyses suggest that a novel SPG3A mutation causes severe phenotypes of hereditary spastic paraplegia

SPAST Intragenic CNVs Lead to Hereditary Spastic Paraplegia via a Haploinsufficiency Mechanism